To determine the current size of the benign prostatic hyperplasia surgical treatment market, this study engaged in four main activities. A comprehensive study was conducted using secondary research methods to gather data about the market, its parent market, and its peer markets. The next stage involved conducting primary research to confirm these conclusions, assumptions, and sizing with industry experts throughout the value chain. A combination of top-down and bottom-up methods was used to assess the overall market size. The market sizes of segments and subsegments were then estimated using data triangulation techniques and market breakdown.
The four steps involved in estimating the market size are
Secondary Research
Within the secondary data collection process, a range of secondary sources were reviewed so as to identify and gather data for this study, including regulatory bodies, databases (like D&B Hoovers, Bloomberg Business, and Factiva), white papers, certified publications, articles by well-known authors, annual reports, press releases, and investor presentations of companies.
Primary Research
In the primary research phase, a comprehensive approach was employed, involving the interviewing of several sources from both the supply and demand sides. The purpose of these interviews was to obtain the quantitative and qualitative information needed to put up this report. The main sources of information were industry experts from both core and related sectors, as well as preferred manufacturers, distributors, suppliers, pioneers in technology, and organizations involved in every aspect of this industry's value chain. A variety of primary respondents, including important industry stakeholders, subject-matter experts, C-level executives from crucial market companies, and industry advisers, were carefully questioned in-depth. The goal was to gather and validate important qualitative and quantitative insights and to conduct a thorough assessment of future possibilities.
A breakdown of the primary respondents is provided below:
Note 1: Others include sales, marketing, and product managers.
Note 2: Tiers of companies are defined based on their total revenue. As of 2023, Tier 1 = >USD 5 billion, Tier 2 = USD 500 million to USD 5 billion, and Tier 3 = < USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
|
COMPANY NAME |
DESIGNATION |
|
Teleflex Incorporated (US) |
Product Manager |
|
Eli Lilly and Company (US) |
Marketing Manager |
|
PROCEPT BioRobotics Corporation (US) |
Regional Manager |
Market Size Estimation
All major product providers offering various products and services were identified at the global/regional level. Revenue mapping was done for the major players and was extrapolated to arrive at the global market value of each type of segment. The market value of benign prostatic hyperplasia surgical treatment market was also split into various segments and subsegments at the region and country level based on:
-
Offering mapping of various manufacturers for each type in the benign prostatic hyperplasia surgical treatment market at the regional and country-level
-
Relative adoption pattern of benign prostatic hyperplasia surgical treatment market among key application segments at the regional and/or country-level
-
Detailed primary research to gather qualitative and quantitative information related to segments and subsegments at the regional and/or country level.
-
Detailed secondary research to gauge the prevailing market trends at the regional and/or country level
Both top-down and bottom-up approaches were used to estimate and validate the total size of benign prostatic hyperplasia surgical treatment market.
Data Triangulation
After arriving at the overall market size by applying the process mentioned above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. By examining a number of variables and patterns from the supply and demand sides, the data was triangulated.
Market Definition
The prostate is a small gland below the bladder that helps make semen. Benign Prostatic Hyperplasia (benign prostatic hyperplasia) is a common condition in aging men characterized by the non-cancerous enlargement of the prostate gland. This enlargement can lead to urinary symptoms as the prostate presses against the urethra, restricting the flow of urine.
benign prostatic hyperplasia surgical treatment refers to various minimally invasive procedures like TURP, laser surgeries, and UroLift, among others.
Stakeholders
-
Manufacturers & Distributors of benign prostatic hyperplasia Surgical devices
-
Hospitals & Clinics
-
Ambulatory Surgery Centers
-
Surgeons & Medical Staff
-
Urologists
-
Healthcare Providers
-
Market Research & Consulting Firms
-
Government Associations
-
Venture Capitalists & Investors
Report Objectives
-
To define, describe, segment, and forecast the benign prostatic hyperplasia surgical treatment market by drug type, type of benign prostatic hyperplasia surgical treatment, therapy, end user, and region
-
To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
-
To assess the benign prostatic hyperplasia surgical treatment market with respect to Porter’s five forces, regulatory landscape, the value chain, the supply chain, ecosystem analysis, patent protection, pricing assessment, key stakeholders, and buying criteria
-
To analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall benign prostatic hyperplasia surgical treatment market
-
To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
-
To forecast the size of the market segments with respect to six regions, namely, North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC Countries
-
To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies 2
-
To track and analyze company developments such as product launches, approvals, acquisitions, agreements, partnerships, and other developments such as regulatory approvals.
-
To benchmark players within the market using the proprietary Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business and product excellence
-
To analyze the impact of AI on the benign prostatic hyperplasia surgical treatment market
HIGHEST CAGR MARKET IN 2023
US FASTEST GROWING MARKET IN THE REGION
Growth opportunities and latent adjacency in Benign Prostatic Hyperplasia Surgical Treatment Market